PHARMACYTE BIOTECH, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
PHARMACYTE BIOTECH, INC. (PMCB) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.20 thousand as of 2022-01-31, per its 10-Q filed 2022-03-15.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2022-03-15
- 2022-01-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.20K.
- 2021-10-31: Lessee, Operating Lease, Liability, to be Paid, Year One $6.88K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2022-01-31 | $2.20K 10-Q · filed 2022-03-15 |
| 2021-10-31 | $6.88K 10-Q · filed 2021-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |